RT Journal Article
SR Electronic
T1 What’s new in prostate cancer screening and prevention?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 439
OP 445
DO 10.3949/ccjm.76a.02009
VO 76
IS 8
A1 Eric A. Klein
YR 2009
UL http://www.ccjm.org/content/76/8/439.abstract
AB Prostate cancer is extremely common but causes death in only a minority of men in whom it develops, facts that raise issues regarding screening and treatment morbidity. Two large trials of screening with prostate-specific antigen (PSA) measurements came to seemingly opposite conclusions. Furthermore, a large trial of selenium and vitamin E found that these agents have no value as preventive agents.